Rachor Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46K Buy
799
+1
+0.1% +$57 0.02% 61
2026
Q1
$48.4K Buy
798
+70
+10% +$4.08K 0.03% 60
2025
Q4
$39.3K Buy
+728
New +$35K 0.02% 57

Other funds holding BMY

Rachor Investment Advisory Services's BMY Position: Q2 2026 in Review

Rachor Investment Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 0.13% in Q2 2026, buying an estimated $57 and bringing the position to 799 shares worth $46K. The position accounts for 0.02% of the portfolio, ranked #61.

Rachor Investment Advisory Services first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $48.4K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Rachor Investment Advisory Services held 799 shares of Bristol-Myers Squibb worth $46K as of Q2 2026.
  • Rachor Investment Advisory Services bought 1 Bristol-Myers Squibb share in Q2 2026, an estimated $57.
  • Bristol-Myers Squibb made up 0.02% of Rachor Investment Advisory Services's portfolio in Q2 2026, its #61 holding.
  • Rachor Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Rachor Investment Advisory Services's Bristol-Myers Squibb position peaked at $48.4K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.